Palvella Therapeutics PVLA Earnings Call Transcripts

NASDAQ PVLA
$168.71 -5.37 (-3.08%)
At close: Nov 10, 2026 · 4:00 PM EST
2 earnings calls on file for Palvella Therapeutics, from Q2 2026 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Palvella Therapeutics Q3 2026 Earnings Call

Nov 5, 2026 8,821 words · 38 min read
  • Bohan WeiVice President of Corporate Development and New Product Planning
  • Wesley H. KaupinenFounder and Executive Officer
  • Ashley KlineChief Commercial Officer
  • Jeff MartiniChief Scientific Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Palvella Therapeutics Earnings Call Transcripts

Calls2
LatestNov 5, 2026
SinceQ2 2026

Fiscal 2026

All 2 Palvella Therapeutics transcripts Register to get access to Palvella Therapeutics’s earnings call transcripts.